{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T04:02:24Z","timestamp":1746417744002,"version":"3.40.4"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"23","license":[{"start":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T00:00:00Z","timestamp":1623369600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Atrial fibrillation (AF) is the most common cardiac arrhythmia and is associated with increased morbidity, especially stroke and heart failure. There is also increasing awareness that atrial fibrillation is a major cause of embolic events which in 75% of cases are complicated by cerebrovascular accidents.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 50-year-old woman with mitral bioprosthesis under warfarin for nonvalvular atrial fibrillation was referred to our Coronary Intensive Care Unit due to acute myocardial infarction without evidence of significant coronary artery stenosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>Cardiovascular examination showed an irregular pulse and a grade II diastolic murmur was audible at the apical area. The patient underwent coronary angiography showing absence of obstructive coronary artery disease. We decided to replace Warfarin with direct oral anticoagulants as anticoagulant therapy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>Transoesophageal echocardiography revealed a thrombus in left atrial appendage that was treated by replacing warfarin with an oral direct thrombin inhibitor.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>At 2-month follow-up, the therapy showed to be effective for thrombus resolution.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>Our case demonstrated how AF has high risk of thromboembolic complications, not only in terms of stroke but also of myocardial infarction and death.<\/jats:p>\n            <jats:p>The use of direct oral anticoagulants in AF patients with bioprosthetic heart valves is still debated due to an unclear definition of \u201cnonvalvular\u201d AF.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000026137","type":"journal-article","created":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T15:08:03Z","timestamp":1623424083000},"page":"e26137","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Intracardiac thrombus in a patient with mitral bioprosthesis and atrial fibrillation treated with direct oral anticoaugulant"],"prefix":"10.1097","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4862-3832","authenticated-orcid":false,"given":"Myriam","family":"D\u2019Angelo","sequence":"first","affiliation":[{"name":"IRCCS Bonino Pulejo of Messina, Cardiology Unit"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Manganaro","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Messina, Cardiology Unit, Azienda Ospedaliera Universitaria \u201cPoliclinico G. Martino\u201d, Messina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Boretti","sequence":"additional","affiliation":[{"name":"IRCCS Bonino Pulejo of Messina, Cardiology Unit"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Giacopelli","sequence":"additional","affiliation":[{"name":"Clinical Research, BIOTRONIK Italia, Vimodrone (MI), Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaetano","family":"Cannav\u00e0","sequence":"additional","affiliation":[{"name":"IRCCS Bonino Pulejo of Messina, Cardiology Unit"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Corallo","sequence":"additional","affiliation":[{"name":"IRCCS Bonino Pulejo of Messina, Cardiology Unit"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Placido","family":"Bramanti","sequence":"additional","affiliation":[{"name":"IRCCS Bonino Pulejo of Messina, Cardiology Unit"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Duca","sequence":"additional","affiliation":[{"name":"IRCCS Bonino Pulejo of Messina, Cardiology Unit"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,6,11]]},"reference":[{"key":"R1-20250504","first-page":"e257","article-title":"Acc\/aha\/esc 2006 guidelines for the management of patients with atrial fibrillation: a report of the American college of cardiology\/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to revise the 2001 guidelines for the management of patients with atrial fibrillation): developed in collaboration with the European heart rhythm association and the heart rhythm society","volume":"114","author":"Fuster","year":"2006","journal-title":"Circulation"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/01.CIR.98.10.946","article-title":"Impact of atrial fibrillation on the risk of death: the framingham heart study","volume":"98","author":"Benjamin","year":"1998","journal-title":"Circulation"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1161\/CIRCULATIONAHA.115.020950","article-title":"Comparison of dabigatran and warfarin in patients with atrial fibrillation and valvular heart disease: the RE-LY (randomized evaluation of long-term anticoagulant therapy)","volume":"134","author":"Ezekowitz","year":"2016","journal-title":"Circulation"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1093\/eurheartj\/ehu305","article-title":"Clinical characteristics and outcomes with rivaroxaban vs warfarin in patients with nonvalvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial","volume":"35","author":"Breithardt","year":"2014","journal-title":"Eur Heart J"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.114.014807","article-title":"Apixaban in comparison with warfarin in patients with atrial fibrillation and valvular heart disease: findings from the apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation (ARISTOTLE) trial","volume":"132","author":"Avezum","year":"2015","journal-title":"Circulation"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.jacc.2016.12.031","article-title":"Valvular heart disease patients on edoxaban or warfarin in the ENGAGE AF-TIMI 48 trial","volume":"69","author":"De Caterina","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS: the task force for the management of atrial fibrillation of the European society of cardiology (ESC). Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Endorsed by the European Stroke Organisation (ESO)","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/europace\/euv309","article-title":"Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation","volume":"17","author":"Hein","year":"2015","journal-title":"Europace"},{"key":"R9-20250504","first-page":"343","article-title":"Oral anticoagulation, stroke and thromboembolism in patients with atrial fibrillation and valve bioprosthesis. Stroke and thromboembolism in patients with AF and biological valve prosthesis","volume":"67","author":"Raphael","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"06","DOI":"10.1093\/europace\/euv288","article-title":"Non-vitamin K antagonist oral anticoagulants in atrial fibrillation accompanying mitral stenosis: the concept for a trial","volume":"18","author":"De Caterina","year":"2016","journal-title":"Europace"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1093\/europace\/eux240","article-title":"ESC Antithrombotic therapy in atrial fibrillation associated with valvular heart disease EHRA CONSENSUS DOCUMENT","volume":"19","author":"Lip","year":"2017","journal-title":"Europace"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1093\/eurheartj\/ehy136","article-title":"The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation","volume":"39","author":"Jan","year":"2018","journal-title":"Eur Heart J"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1161\/CIRCULATIONAHA.116.026714","article-title":"Edoxaban for the prevention of thromboembolism in patients with atrial fibrillation and bioprosthetic valves","volume":"135","author":"Carnicelli","year":"2017","journal-title":"Circulation"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"e568-e571","DOI":"10.1002\/clc.23178","article-title":"Efficacy and safety of apixaban vs warfarin in patients with atrial fibrillation and prior bioprosthetic valve replacement or valve repair: insights from the ARISTOTLE trial","volume":"42","author":"Guimaraes","year":"2019","journal-title":"Clin Cardiol"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s40268-016-0124-1","article-title":"Dabigatran versus warfarin after bioprosthesis valve replacement for the management of atrial fibrillation postoperatively: DAWA pilot study","volume":"16","author":"Duraes","year":"2016","journal-title":"Drugs R D"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1016\/j.clinthera.2019.10.008","article-title":"Clinical benefit of direct oral anticoagulants vs vitamin K antagonists in patients with atrial fibrillation and bioprosthetic heart valves","volume":"41","author":"Russo","year":"2019","journal-title":"Clin Ther"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000026137","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T05:36:25Z","timestamp":1746336985000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000026137"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2021,6,11]]},"references-count":16,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000026137","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2021,6,11]]},"assertion":[{"value":"2021-02-25","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-11","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}